Aristotle University of Thessaloniki-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2024

  1. Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study

    Alzheimer's and Dementia

  2. Blood-based multivariate methylation risk score for cognitive impairment and dementia

    Alzheimer's and Dementia

2022

  1. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

    JAMA Neurology, Vol. 79, Núm. 3, pp. 228-243

2018

  1. MRI predictors of amyloid pathology: Results from the EMIF-AD Multimodal Biomarker Discovery study

    Alzheimer's Research and Therapy, Vol. 10, Núm. 1

2016

  1. Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study

    Alzheimer's and Dementia, Vol. 12, Núm. 2, pp. 154-163

2015

  1. The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey

    Alzheimer's and Dementia, Vol. 11, Núm. 2, pp. 195-206.e1

2012

  1. Progression of Alzheimer disease in Europe: Data from the European ICTUS study

    Current Alzheimer Research, Vol. 9, Núm. 8, pp. 902-912

2010

  1. Caregiver insights into optimal dementia management

    25TH INTERNATIONAL CONFERENCE OF ALZHEIMERS DISEASE INTERNATIONAL

  2. Drug profile: Transdermal rivastigmine patch in the treatment of alzheimer disease

    CNS Neuroscience and Therapeutics, Vol. 16, Núm. 4, pp. 246-253

  3. Turning principles into practice in Alzheimer's disease

    International Journal of Clinical Practice, Vol. 64, Núm. 9, pp. 1198-1209